跳至主要内容
临床试验/NCT00655889
NCT00655889已完成2 期

Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency

Castle Creek Biosciences, LLC.2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2006年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
13
试验地点
2
主要终点
Number of Responders Based on the Average Investigator Evaluation of Change From Baseline for All Treated Areas on the Global Ordinal Rating Scale (GORS)

研究概览

简要总结

The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM in subjects with maxillary lesions who were treated in a previous study (IT-G-002, no NCT identification number)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must be 18-70 years of age
  • Subject was treated in IT-G-002 (no NCT identification number)
  • Subject has maxillary interproximal recession defects
  • Natural teeth must be present on both sides of each area to be treated
  • Negative pregnancy test and use of acceptable birth control (females of childbearing age)

排除标准

  • Subjects who participated in other clinical trials within 30 days prior to enrollment
  • Interproximal spaces including root grooves or furcations must not be involved
  • Subjects with poor oral hygiene
  • Subjects with a systemic condition, which would preclude periodontal treatment
  • Subjects with acute infectious lesions in the treatment areas
  • Subjects with open interproximal contact at study sites
  • Subjects who must receive prophylactic antibiotics before dental procedures
  • Subjects on chronic antibiotic or steroidal therapy
  • Subjects with interproximal probing depths > 3 mm around study lesions
  • Subjects who smoke
  • Subjects taking medications associated with the development of drug induced gingival hyperplasia
  • Subjects with radiographic evidence of pathology
  • Subjects with tooth mobility exceeding a score of 1
  • Subjects with parafunctional habits and not wearing bite guard
  • Subjects with interproximal spaces associated with teeth without an adequate zone of keratinized tissue
  • Subjects where the etiology of the interproximal papillary recession has not been controlled
  • Subjects who have received a crown or pontic on one or both teeth involved in the interproximal space to be treated

结局指标

主要结局

Number of Responders Based on the Average Investigator Evaluation of Change From Baseline for All Treated Areas on the Global Ordinal Rating Scale (GORS)

时间窗: Baseline (prior to first study treatment) compared to six months after first treatment

A patient was considered a responder in this outcome measure if the average Investigator's GORS score for all treatment areas was greater than 0. On the GORS, a score of -2 (much worsening from baseline) was the worst and +2 (great improvement from baseline) was the best.

Number of Responders Based on the Average Patient Evaluation of Change From Baseline for All Treated Areas on the Global Ordinal Rating Scale (GORS)

时间窗: Baseline (prior to first study treatment) compared to six months after first treatment

A patient was considered a responder in this outcome measure if the average patient's GORS score for all treatment areas was greater than 0. On the GORS, a score of -2 (much worsening from baseline) was the worst and +2 (great improvement from baseline) was the best.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Safety and Efficacy Study of Isolagen TherapyTM in... | 临床试验